Hughes Owen

CIK 00015759338 companiesEMERYVILLE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001575933

Recent Transactions

50 trades

Disposition to Issuer
XOMA Royalty Corp
Performance Stock Units
2026-07-14−132,714→ 0 total
Other
XOMA Royalty Corp
Common Stock
2026-07-14−191,264→ 0 total
Other
XOMA Royalty Corp
Common Stock
2026-07-14−752→ 0 total
Disposition to Issuer
XOMA Royalty Corp
Depositary Shares - 8.375% Series B Cumulative Stock
2026-07-14−102,000→ 0 total
Disposition to Issuer
XOMA Royalty Corp
Stock Option (Right to Buy)
2026-07-14−100,000→ 0 total
Disposition to Issuer
XOMA Royalty Corp
Stock Option (Right to Buy)
2026-07-14−75,000→ 0 total
Disposition to Issuer
XOMA Royalty Corp
Performance Stock Units
2026-07-14−116,245→ 0 total
Award
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2026-06-24+62,000→ 62,000 total
Award
ANAPTYSBIO, INC$ANAB
Restricted Stock Units
2026-05-11+11,250→ 11,250 total
Exercise/Conversion
XOMA Royalty Corp
Common Stock
2026-04-20+10,568→ 191,264 total
Exercise/Conversion
XOMA Royalty Corp
Performance Stock Units
2026-04-20−10,568→ 116,245 total
Award
XOMA Royalty Corp
Performance Stock Units
2026-03-16+126,813→ 126,813 total
Award
XOMA Royalty Corp
Common Stock
2026-03-16+82,428→ 180,696 total
Purchase
XOMA Royalty Corp
Depositary Shares - 8.375% B Cumulative Stock
2025-12-04$25.05/sh+100,000→ 102,000 total
Exercise/Conversion
XOMA Royalty Corp
Common Stock
2025-09-19+35,567→ 98,268 total
Exercise/Conversion
XOMA Royalty Corp
Performance Stock Units
2025-09-19−35,567→ 132,714 total
Award
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2025-06-18+35,500→ 35,500 total
Sale
XOMA Royalty Corp
Common Stock
2025-05-20$25.38/sh−25,637→ 62,701 total
Exercise/Conversion
XOMA Royalty Corp
Common Stock
2025-05-19+53,359→ 88,338 total
Exercise/Conversion
XOMA Royalty Corp
Performance Stock Units
2025-05-19−53,359→ 168,281 total
Sale
XOMA Royalty Corp
Common Stock
2024-11-13$29.95/sh−21,881→ 34,979 total
Exercise/Conversion
XOMA Royalty Corp
Performance Stock Units
2024-11-11−53,360→ 221,640 total
Exercise/Conversion
XOMA Royalty Corp
Common Stock
2024-11-11+53,360→ 56,860 total
Award
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2024-06-20+32,500→ 32,500 total
Award
ImageneBio, Inc.$IMA
Stock Option (Right to Buy)
2024-06-07+17,520→ 17,520 total
Award
XOMA Royalty Corp
Performance Stock Units
2024-01-08+275,000→ 275,000 total
Award
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2023-11-16+52,000→ 52,000 total
Purchase
XOMA Royalty Corp
Common Stock
2023-10-02$13.83/sh+1,000→ 3,500 total
Purchase
XOMA Royalty Corp
Common Stock
2023-09-26$14.43/sh+2,499→ 2,500 total
Purchase
XOMA Royalty Corp
Common Stock
2023-09-25$14.65/sh+1→ 1 total
Award
ImageneBio, Inc.$IMA
Stock Option (Right to Buy)
2023-06-09+17,520→ 17,520 total
Purchase
XOMA Royalty Corp
Depositary Shares - 8.375% B Cumulative Stock
2023-05-24$23.79/sh+1,032→ 2,000 total
Purchase
XOMA Royalty Corp
Depositary Shares - 8.375% B Cumulative Stock
2023-05-23$23.33/sh+200→ 200 total
Purchase
XOMA Royalty Corp
Depositary Shares - 8.375% B Cumulative Stock
2023-05-23$23.49/sh+768→ 968 total
Award
XOMA Royalty Corp
Employee Stock Option (right to buy)
2023-01-03+100,000→ 100,000 total
Award
XOMA Royalty Corp
Employee Stock Option (right to buy)
2023-01-03+75,000→ 75,000 total
Award
ImageneBio, Inc.$IMA
Stock Option (Right to Buy)
2022-12-15+35,040→ 35,040 total
Disposition from Tender
Radius Health, Inc.
Common Stock
2022-08-15$10.00/sh−21,650→ 0 total
Disposition to Issuer
Radius Health, Inc.
Stock Option (Right to Buy)
2022-08-15$3.60/sh−10,000→ 0 total
Disposition to Issuer
Radius Health, Inc.
Stock Option (Right to Buy)
2022-08-15$2.00/sh−32,894→ 0 total
Award
Radius Health, Inc.
Stock Option (Right to Buy)
2022-01-14+10,000→ 10,000 total
Award
Radius Health, Inc.
Common Stock
2022-01-14+5,500→ 21,650 total
Conversion
PARDES BIOSCIENCES, INC.
Class A Common Stock
2021-12-23+52,500→ 52,500 total
Conversion
PARDES BIOSCIENCES, INC.
Class B Common Stock
2021-12-23−52,500→ 0 total
Conversion
PARDES BIOSCIENCES, INC.
Class A Common Stock
2021-12-23+30,000→ 30,000 total
Conversion
PARDES BIOSCIENCES, INC.
Class B Common Stock
2021-12-23−30,000→ 0 total
Sale
Translate Bio, Inc.
Stock Option (righ to buy)
2021-09-14−20,000→ 0 total
Sale
Translate Bio, Inc.
Common Stock
2021-09-14$38.00/sh−29,860→ 0 total
Sale
Translate Bio, Inc.
Stock Option (right to buy)
2021-09-14−38,135→ 0 total
Sale
Translate Bio, Inc.
Stock Option (right to buy)
2021-09-14−18,900→ 0 total

Companies

Recent Filings

Address

C/O XOMA ROYALTY CORPORATION 2200 POWELL STREET, SUITE 310

EMERYVILLE, CA, 94608

View on SEC.gov